HLA class II neoantigen presentation for CD4+ T cell surveillance in HLA class II-negative colorectal cancer
Neoantigen-reactive CD4+ T cells play a key role in the anti-tumor immune response. However, the majority of epithelial tumors are negative for HLA class II (HLA-II) surface expression, and less is known about the processing of HLA-II antigens. Here, we directly identified naturally presented HLA-II...
        Saved in:
      
    
          | Main Authors: | Satoru Matsumoto, Takahiro Tsujikawa, Serina Tokita, Mai Mohamed Bedeir, Kazuhiko Matsuo, Fumitake Hata, Yoshihiko Hirohashi, Takayuki Kanaseki, Toshihiko Torigoe | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Taylor & Francis Group
    
        2024-12-01 | 
| Series: | OncoImmunology | 
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2404665 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    LRMAHpan: a novel tool for multi-allelic HLA presentation prediction using Resnet-based and LSTM-based neural networks        
                          
 by: Xue Mi, et al.
 Published: (2024-11-01)
- 
                
                    HLA Class I (A and B) Allele Polymorphism in a Moroccan Population Infected with Hepatitis C Virus        
                          
 by: Safa Machraoui, et al.
 Published: (2024-12-01)
- 
                
                    The Effects of HLA-G Gene Polymorphism and sHLA-G Level in Women with Threatened Abortion        
                          
 by: Ahmed H. Merdas, et al.
 Published: (2022-06-01)
- 
                
                    Associations of HLA-G 3’UTR polymorphisms and increased HLA-G expression with gastric cancer susceptibility and prognosis        
                          
 by: Ines Zemni, et al.
 Published: (2025-01-01)
- 
                
                    Negative Association of Gulf War Illness Symptomatology with Predicted Binding Affinity of Anthrax Vaccine Antigen to Human Leukocyte (HLA) Class II Molecules        
                          
 by: Lisa M. James, et al.
 Published: (2025-01-01)
 
       